Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

1.84
+0.310020.26%
Post-market: 1.79-0.0500-2.72%19:52 EDT
Volume:282.18K
Turnover:480.26K
Market Cap:11.14M
PE:-0.08
High:1.84
Open:1.56
Low:1.55
Close:1.53
Loading ...

BioXcel Therapeutics: Serenity Phase 3 Safety Trial Topline Data Expected in H2 2025

THOMSON REUTERS
·
07 Mar

BioXcel Therapeutics Announces 33% Enrollment in Serenity at-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated With Bipolar Disorders or Schizophrenia

THOMSON REUTERS
·
07 Mar

ScPharmaceuticals, Inc. (SCPH) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
05 Mar

BRIEF-Bioxcel Therapeutics Announces Closing Of $14 Million Registered Direct Offering

Reuters
·
05 Mar

BioXcel Therapeutics Announces Closing of $14 Million Registered Direct Offering

THOMSON REUTERS
·
05 Mar

BioXcel Therapeutics, Inc. (BTAI) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Zacks
·
04 Mar

BioXcel Therapeutics Announces $14 Million Registered Direct Offering

THOMSON REUTERS
·
04 Mar

Press Release: BioXcel Therapeutics Announces $14 Million Registered Direct Offering

Dow Jones
·
04 Mar

Top Midday Gainers

MT Newswires Live
·
04 Mar

BioXcel Therapeutics Inc - FDA Designates 'Voluntary Action Indicated' for Tranquility Ii Site

THOMSON REUTERS
·
03 Mar

BioXcel Therapeutics Inc - Believes FDA Report Supports Tranquility Ii Data Reliability

THOMSON REUTERS
·
03 Mar

BioXcel Therapeutics Announces FDA Closed Its Inspection of Site for Phase 3 Tranquility Ii Trial for Acute Treatment of Agitation Associated With Alzheimer’s Dementia

THOMSON REUTERS
·
03 Mar

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires Live
·
01 Mar

BioXcel Therapeutics Regains Nasdaq Compliance

MT Newswires Live
·
28 Feb

Wall Street Set to Open Higher Friday as Inflation Data Meets Expectations

MT Newswires Live
·
28 Feb

US Stock Futures Rise as Investors Await Key Inflation Data

MT Newswires Live
·
28 Feb

Top Premarket Gainers

MT Newswires Live
·
28 Feb

BioXcel Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Rule

THOMSON REUTERS
·
28 Feb

BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule

GlobeNewswire
·
28 Feb

BioXcel to Implement Reverse Stock Split; Shares Fall

MT Newswires Live
·
07 Feb